Scott Wagner - 21 Jan 2026 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Director
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Scott Wagner
Issuer symbol
GDRX
Transactions as of
21 Jan 2026
Net transactions value
$0
Form type
4
Filing time
21 Jan 2026, 17:20:35 UTC
Previous filing
03 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wagner Scott Director C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA /s/ Gracye Cheng, Attorney-in-Fact for Scott Wagner 21 Jan 2026 0001342655

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise +31,394 +17% 216,663 21 Jan 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Deferred Stock Unit Options Exercise $0 -31,394 -33% $0.000000 62,788 21 Jan 2026 Class A Common Stock 31,394 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The deferred stock unit award vested as to one-third of the shares underlying the award on January 21, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
F2 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.